DR. SAMIT HIRAWAT, M.D.
Osteopathic Medicine at Buxton Rd, Chatham Township, NJ
License number
New Jersey 25MA07813100
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
5 Buxton Rd, Chatham Township, NJ 07928
Phone
(973) 701-0808
Organization information
See more information about SAMIT HIRAWAT at bizstanding.comSamit Hirawat MD
12 Pne St, Chatham, NJ 07928
Industry:
Internist
Phone:
(973) 701-0808 (Phone)
Samit Hirawat
Professional information
Methods For Treating Breast Cancer
US Patent:
2012020, Aug 9, 2012
Filed:
May 27, 2010
Appl. No.:
13/321271
Inventors:
Thomas W. Davis - South Orange NJ, US
Samit Hirawat - Chatham NJ, US
Harry H. Miao - Wellesley MA, US
Langdon Miller - Seattle WA, US
Charles M. Romfo - Easton PA, US
Marla L. Weetall - Morristown NJ, US
Samit Hirawat - Chatham NJ, US
Harry H. Miao - Wellesley MA, US
Langdon Miller - Seattle WA, US
Charles M. Romfo - Easton PA, US
Marla L. Weetall - Morristown NJ, US
International Classification:
A61K 31/541, A61K 31/496, A61K 31/5377, A61K 31/4375, A61P 35/00
US Classification:
5142282, 514292, 5142328, 51425303
Abstract:
Methods for treating breast cancer involving the administration of a compound that selectively inhibits pathological production of human vascular endothelial growth factor (VEGF) are described. The compound can be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatment.
Administration Of Carboline Derivatives Useful In The Treatment Of Cancer And Other Diseases
US Patent:
2010015, Jun 24, 2010
Filed:
Apr 12, 2008
Appl. No.:
12/595134
Inventors:
Samit Hirawat - Chatham NJ, US
Langdon Miller - Lebanon NJ, US
Gary Elfring - Lebanon NJ, US
Thomas Davis - South Orange NJ, US
Marla L. Weetall - Morristown NJ, US
Langdon Miller - Lebanon NJ, US
Gary Elfring - Lebanon NJ, US
Thomas Davis - South Orange NJ, US
Marla L. Weetall - Morristown NJ, US
International Classification:
A61K 38/20, A61K 38/21, A61K 39/395, A61K 31/66, A61K 31/551, A61K 31/5377, A61K 31/497, A61K 31/506, C07D 413/14, C07D 471/04, A61P 35/00
US Classification:
424 852, 424 857, 4241331, 514130, 514218, 5142328, 51425303, 51425505, 514275, 540575, 544126, 544331, 544361, 544405
Abstract:
In accordance with the present invention, compounds are provided which are useful in a method or in the manufacture of a medicament for post-transcriptionally inhibiting the expression of VEGF in a subject in need thereof comprising inhibiting VEGF mRNA translation by orally administering said medicament once, twice or thrice daily to the subject.
Methods For Treating Brain Tumors
US Patent:
2012015, Jun 21, 2012
Filed:
May 27, 2010
Appl. No.:
13/321252
Inventors:
Thomas W. Davis - South Orange NJ, US
Samit Hirawat - Chatham NJ, US
Harry H. Miao - Wellsley MA, US
langdon Miller - Seattle WA, US
Marla Weetall - Morristown NJ, US
Samit Hirawat - Chatham NJ, US
Harry H. Miao - Wellsley MA, US
langdon Miller - Seattle WA, US
Marla Weetall - Morristown NJ, US
International Classification:
A61K 31/437, A61K 31/496, A61K 31/541, A61P 35/00, A61K 31/695, A61K 31/706, A61K 31/501, A61K 31/5377, A61K 31/53
US Classification:
514 43, 514292, 5142328, 51425303, 5142282, 514245, 514 63, 51425204
Abstract:
Methods for treating brain tumors involving the administration of a compound that selectively inhibits pathological production of human VEGF are described. The compound can be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatment.
Methods For Treating Kaposi Sarcoma
US Patent:
2012015, Jun 21, 2012
Filed:
May 27, 2010
Appl. No.:
13/321233
Inventors:
Thomas W. Davis - South Orange NJ, US
Samit Hirawat - Chatham NJ, US
Harry H. Miao - Wellsley MA, US
Langdon Miller - Seattle WA, US
Marla L. Weetall - Morristown NJ, US
Samit Hirawat - Chatham NJ, US
Harry H. Miao - Wellsley MA, US
Langdon Miller - Seattle WA, US
Marla L. Weetall - Morristown NJ, US
International Classification:
A61K 31/437, A61K 31/496, A61K 31/541, A61P 35/00, A61K 31/506, A61K 31/706, A61K 31/501, A61K 31/695, A61K 31/5377, A61K 31/53
US Classification:
514 43, 514292, 5142328, 51425303, 5142282, 514245, 514274, 51425204, 514 63
Abstract:
Methods for treating Kaposi's sarcoma involving the administration of a compound that selectively inhibits pathological production of human VEGF are described. The compound can be administered as a single-agent therapy or in combination with one or more additional therapies to a human in need of such treatment.